Minerva Neurosciences, Inc NERV
3.40
(0.05)
(1.45%)
as of 25 Sep
- Market cap
- $164.7M
- P/E
- 0.0×
Follow NERV
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
4.64 | 35.98 | 17.44 | 19.04 | |
Current Ratio |
4.87 | 36.28 | 17.65 | 20.14 | |
Net Debt/EBITDA |
4.36 | 16.55 | 4.65 | 6.83 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.06 | 0.02 | 0.04 | (0.80) | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.53 | 0.15 | 0.16 | 0.16 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.39) | (0.53) | (0.12) | (0.29) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.39) | (0.53) | (0.12) | (0.29) | |
Cash per Share |
1.64 | 9.74 | 1.78 | 1.62 | |
Shareholders Equity per Share |
(4.57) | (16.63) | (5.79) | (4.58) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(4.57) | (16.63) | (5.79) | (4.58) | |
Free Cash Flow |
(2.92) | (4.48) | (5.43) | (13.34) | |
Working Capital |
10.35 | 80.81 | 74.62 | 75.77 | |
Net Current Asset Value |
(49.65) | (155.62) | (268.93) | (228.66) | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
0.75 | 1.12 | 1.38 | 1.17 | |
Average Assets |
35.45 | 67.56 | 63.41 | 62.75 | |
Average Common Equity |
(28.13) | (83.22) | (141.58) | (122.70) |
Columns are period end dates